Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Medgenics Inc. - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 20 | Code: MRS - 18617


Global Markets Directs, Medgenics Inc. Product Pipeline Review 2014, provides an overview of the Medgenics Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medgenics Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Medgenics Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Medgenics Inc.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Medgenics Inc.s pipeline products

Reasons to buy

Evaluate Medgenics Inc.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Medgenics Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Medgenics Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Medgenics Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medgenics Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Medgenics Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content

Table of Contents 2
List of Tables 3
List of Figures 3
Medgenics Inc. Snapshot 4
Medgenics Inc. Overview 4
Key Information 4
Key Facts 4
Medgenics Inc.- Research and Development Overview 5
Key Therapeutic Areas 5
Medgenics Inc.- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Medgenics Inc.- Pipeline Products Glance 9
Medgenics Inc.- Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Medgenics Inc.- Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Medgenics Inc.- Drug Profiles 11
MDGN-201 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
MDGN-204 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
MDGN-205 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
MDGN-206 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Medgenics Inc.- Pipeline Analysis 15
Medgenics Inc.- Pipeline Products by Target 15
Medgenics Inc.- Pipeline Products by Molecule Type 16
Medgenics Inc.- Recent Pipeline Updates 17
Medgenics Inc.- Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18

Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20

List of Tables

Medgenics Inc., Key Information 4
Medgenics Inc., Key Facts 4
Medgenics Inc.- Pipeline by Indication, 2014 6
Medgenics Inc.- Pipeline by Stage of Development, 2014 7
Medgenics Inc.- Monotherapy Products in Pipeline, 2014 8
Medgenics Inc.- Phase I, 2014 9
Medgenics Inc.- Preclinical, 2014 10
Medgenics Inc.- Pipeline by Target, 2014 15
Medgenics Inc.- Pipeline by Molecule Type, 2014 16
Medgenics Inc.- Recent Pipeline Updates, 2014 17
Medgenics Inc., Other Locations 18
Medgenics Inc., Subsidiaries 18

List of Figures

Medgenics Inc. - Pipeline by Top 10 Indication, 2014 6
Medgenics Inc. - Pipeline by Stage of Development, 2014 7
Medgenics Inc. - Monotherapy Products in Pipeline, 2014 8
Medgenics Inc. - Pipeline by Top 10 Target, 2014 15
Medgenics Inc. - Pipeline by Top 10 Molecule Type, 2014 16

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing